Sandoz files anti-dumping complaint on Chinese imports
Sandoz filed a complaint with the European Commission over Chinese amoxicillin imports. The firm warns that subsidies threaten Europe's drug supply security.
Xurve View
Insights:
Xurve View
Sandoz Group AG filed a draft anti-dumping complaint with the European Commission on May 28 regarding amoxicillin imports from China. The Switzerland-based drugmaker claims Chinese competitors use state subsidies and below-cost pricing to dominate the penicillin market. The move seeks to protect the only remaining vertically integrated production network for penicillins left in Europe.
